Close Menu

NEW YORK – Bionano Genomics has again fallen out of compliance with Nasdaq listing requirements.

According to an April 24 filing with the US Securities and Exchange Commission, the genome mapping firm received a letter from Nasdaq on April 22, stating that for 30 consecutive days, its share price had closed below the $1.00 minimum required for continued listing.

At the close of the market on April 24, shares of Bionano traded at $.35.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.